📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies. (2017)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.13884

PubMed Identifier: 27965461

Publication URI: http://europepmc.org/abstract/MED/27965461

Type: Journal Article/Review

Volume: 8

Parent Publication: Oncotarget

Issue: 2

ISSN: 1949-2553